0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessBram Herpers, Berina Eppink, Mark I. James, Carme Cortina, Adrià Cañellas‐Socias, Sylvia F. Boj, Xavier Hernando‐Momblona, Dominik Głodzik, Rob C. Roovers, Marc van de Wetering, Carina Bartelink-Clements, Vanessa Zondag-van der Zande, Jara García Mateos, Kuan Yan, Lucia Salinaro, Abdul Basmeleh, Szabolcs Fátrai, David Maussang, Jeroen J. Lammerts van Bueren, Irene Chicote, Garazi Serna, Laia Cabellos, Lorena Ramírez, Paolo Nucíforo, Ramón Salazar, Cristina Santos, Alberto Villanueva, Camille Stephan‐Otto Attolini, Elena Sancho, Héctor G. Pálmer, Josep Tabernero, Michael R. Stratton, John de Kruif, Ton Logtenberg, Hans Clevers, Leo Price, Robert G.J. Vries, Eduard Batlle, Mark Throsby (2022). Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors. , 3(4), DOI: https://doi.org/10.1038/s43018-022-00359-0.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2022
Authors
39
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1038/s43018-022-00359-0
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
